Industry and Business Archives - Oncology Central Oncology Central

i
i

23 Jan 2019 News
Oncology conference and event highlights: January–March 2019
9 Jan 2019 Immuno-oncology
Our top oncology content of 2018 – a note from the Editor
9 Jan 2019 Cancer biology and pathology
Clinical trial aims to produce a breath test to identify early-stage cancer
30 Nov 2018 Skin
PD-1 immunotherapy, nivolumab, made available on the NHS for melanoma patients
27 Nov 2018 Industry and business
US FDA approves larotrectinib, a unique DNA-targeting drug, for NTRK+ cancers
23 Nov 2018 Lung
Keytruda® gets the green light from NICE for untreated lung cancer
9 Nov 2018
NICE recommends new first-line treatment Lenvima against advanced liver cancer
31 Oct 2018 Immuno-oncology
Plinabulin: a novel immuno-oncology agent for the treatment of chemotherapy-induced neutropenia and advanced NSCLC
29 Oct 2018 Prostate
Court invalidates patent for prostate cancer drug Zytiga®
24 Oct 2018 Head and neck
KEYNOTE-048: pembrolizumab changes the rules for head and neck cancer patients
1 Oct 2018 Skin
FDA approves first and only treatment for advanced cutaneous squamous cell carcinoma
28 Sep 2018 Surgical oncology
A dog’s 3D printed implant shows potential for cancer surgeries